Funded Tech Companies
CytoMed Therapeutics
CytoMed Therapeutics is a biopharmaceutical tech company, based in Singapore. Venture capital investment was provided by ICH Capital.
Company Overview
Company Name
CytoMed Therapeutics
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
Undisclosed
Singapore, Undisclosed
Singapore
Singapore, Undisclosed
Singapore
Phone
Undisclosed
Website
Email Address
Not Recorded
Company Background Information
Overview
CytoMed was spun off from the Agency for Science, Technology and Research (A*STAR), Singapore's leading research and development agency in the public sector. CytoMed is a clinical stage biopharmaceutical company focused on harnessing its licensed proprietary technologies, namely gamma delta T cell and iPSC-derived gamma delta Natural Killer T cell, to create novel cell-based allogeneic immunotherapies for the treatment of various human cancers. The development of novel technologies has been inspired by the clinical success of existing CAR-T therapies in treating haematological malignancies, as well as the current clinical limitations and commercial challenges in extrapolating the CAR-T principle into the treatment of solid tumours.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
11/6/2025
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chairman
CHOO Kong
Company Investors
- ICH Capital (Vincent Toe)
Browse more funded tech companies:
Share this article
About Our VC Deals Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs